The company is listed on the main board of the Shenzhen Stock Exchange. The company's main business is pharmaceuticals. The company adheres to the research and development concept of “tailor-made children's medicine”, with the mission and vision of “making tens of millions of Chinese children healthy and strong, and a leading enterprise in the field of child health care and treatment”, and the value concept of “work seriously and act with integrity”, focusing on medicine, innovation and empowerment, strengthening and improving the child health industry cluster, and achieving the company's high-quality leapfrog development. The company is mainly engaged in pharmaceutical business. Icosin vitamin AD drops, vitamin D drops, dextran iron granules, compound calcium carbonate effervescent granules, zinc licorice granules, oral rehydration salts, pediatric ibuprofen suppositories, atomoxetine hydrochloride oral solution, and desloratadine oral solution. Company honors include Gold Medal Product, Provincial Fumin Xinglu Labor Award, Shandong Famous Trademark, Provincial Light Industry Association Advanced Enterprise, “2022 Chinese Pharmaceutical Industry Top 100”, “National Pharmaceutical Industry Quality Leading Enterprise”, “National Pharmaceutical Industry Quality Leading Brand”, “National Pharmaceutical Industry Quality Leading Brand”, etc.; “Top 50 Pharmaceutical Industry Growth Enterprises in the 2021-2023 Pharmaceutical Industry”, “Top 100 Pharmaceutical Manufacturing Companies in Shandong Province”, “Shandong Quality Luyao Construction Demonstration Enterprise” and “2023 China's Non-prescription Drug Gold Single Product”, etc.; Yikexin won honors such as “The brand with the highest recommendation rate by Chinese pharmacy clerks”; it was on the “2023 Health Industry Brand List” and won the highest honor “Shipgold Award”.
No Data
No Data